atezolizumab

atezolizumab is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Genetic Implications: Genetic Implications

Pronunciation:
a-te-zoe-liz-ue-mab


Trade Name(s)

  • Tecentriq

Ther. Class.
antineoplastics

Pharm. Class.
monoclonal antibodies
programmed death ligand 1 (PD-L1) inhibitors

-- To view the remaining sections of this topic, please or --

General

Genetic Implications: Genetic Implications

Pronunciation:
a-te-zoe-liz-ue-mab


Trade Name(s)

  • Tecentriq

Ther. Class.
antineoplastics

Pharm. Class.
monoclonal antibodies
programmed death ligand 1 (PD-L1) inhibitors

There's more to see -- the rest of this entry is available only to subscribers.